Hyperandrogenism may explain reproductive dysfunction in olympic athletes

Medicine and Science in Sports and Exercise

Volumn 41, Issue 6, 2009, Pages 1241-1248

  Hagmar, Magnus ^a,b   Berglund, Bo ^a   Brismar, Kerstin ^a   Hirschberg, Anhrlica Lindin ^a  

^a KAROLINSKA INSTITUTE   (Sweden)

^b KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

Author keywords

Bone mineral density; Female athlete triad; Female athletes; Ppolycystic ovary syndrome

Indexed keywords

BIOLOGICAL MARKER; GLUCOSE; HYDROCORTISONE; INSULIN; ORAL CONTRACEPTIVE AGENT; SOMATOMEDIN BINDING PROTEIN 1; SOMATOMEDIN C;

ADULT; ARTICLE; ATHLETE; BLOOD SAMPLING; BODY COMPOSITION; BODY FAT; BONE DENSITY; BONE MINERAL; DUAL ENERGY X RAY ABSORPTIOMETRY; ENDURANCE SPORT; FEMALE; FEMALE ATHLETE TRIAD; HORMONE BLOOD LEVEL; HUMAN; HYPERANDROGENISM; MAJOR CLINICAL STUDY; MENSTRUATION DISORDER; OSTEOPENIA; OVARY POLYCYSTIC DISEASE; RADIOIMMUNOASSAY; SPORT; ECHOGRAPHY; EXERCISE TOLERANCE; REGRESSION ANALYSIS; VAGINA;

ADULT; BIOLOGICAL MARKERS; BODY COMPOSITION; BONE DENSITY; EXERCISE TOLERANCE; FEMALE; FEMALE ATHLETE TRIAD SYNDROME; HUMANS; POLYCYSTIC OVARY SYNDROME; REGRESSION ANALYSIS; SPORTS; VAGINA;

EID: 67650077361     PISSN: 01959131     EISSN: 15300315     Source Type: Journal    
DOI: 10.1249/MSS.0b013e318195a21a     Document Type: Article

References (36)

1. Balogh A. Kauf E. Vollanth R. Graser G. Klinger G. Oettel M. Effects of two oral contraceptives on plasma levels of insulin-like growth factor I (IGF-I) and growth hormone (hGH). Contraception.2000;62(5):259-69.
2. Bang P. Eriksson U. Sara V. Wivall IL. Hall K. Comparison of acid ethanol extraction and acid gel filtration prior to IGF-I and IGF-II radioimmunoassays: improvement of determinations in acid ethanol extracts by the use of truncated IGF-I as radioligand. Acta Endocrinol (Copenh).1991;124(6):620-9.
3. Brismar TB. Ringertz J. Effect of bone density of the head on total body DEXA measurements in 100 healthy Swedish women. Acta Radiol.1996;37(1): 101-6.
4. Cardinale M. Stone MH. Is testosterone influencing explosive performance? J Strength Cond Res.2006;20(1):103-7.
5. De Souza MJ. Lee DK. Van Heest JL. Scheid JL. West SL. Williams NI. Severity of energy-related menstrual disturbances increases in proportion to indices of energy conservation in exercising women. Fertil Steril.2007;88(4):971-5.
6. De Souza MJ. Williams NI. Beyond hypoestrogenism in amen-orrheic athletes: energy deficiency as a contributing factor for bone loss. Curr Sports Med Rep.2005;4(1):38-44.
7. Fleck SJ. Body composition of elite American athletes. Am J Sports Med.1983;11(6):398-403.
8. Franks S. Controversy in clinical endocrinology: diagnosis of polycystic ovarian syndrome: in defense of the Rotterdam criteria. J Clin Endocrinol Metab.2006;91(3):786-9.
9. Frisch RE. Body fat. menarche. fitness and fertility. Hum Reprod.1987;2(6):521-33.
10. Goswamy RK. Campbell S. Whitehead MI. Screening for ovarian cancer. Clin Obstet Gynaecol.1983;10(3):621-43.
11. Hagmar M. Hirschberg AL. Berglund L. Berglund B. Special attention to the weight-control strategies employed by Olympic athletes striving for leanness is required. Clin J Sport Med.2008;18(1):5-9.
12. Hilding A. Brismar K. Degerblad M. Thoren M. Hall K. Altered relation between circulating levels of insulin-like growth factor-binding protein-1 and insulin in growth hormone-deficient patients and insulin-dependent diabetic patients compared to that in healthy subjects. J Clin Endocrinol Metab.1995;80(9):2646-52.
13. Joy EA. Campbell D. Stress fractures in the female athlete. Curr Sports Med Rep.2005;4(6):323-8.
14. Larsson M. Aneblom G. Odlind V. Tyden T. Reasons for pregnancy termination. contraceptive habits and contraceptive failure among Swedish women requesting an early pregnancy termination. Acta Obstet Gynecol Scand.2002;81(1):64-71.
15. Laughlin GA. Yen SS. Nutritional and endocrine-metabolic aberrations in amenorrheic athletes. J Clin Endocrinol Metab.1996;81(12):4301-9.
16. Loucks AB. Energy balance and body composition in sports and exercise. J Sports Sci.2004;22(1):1-14.
17. Loucks AB. Thuma JR. Luteinizing hormone pulsatility is disrupted at a threshold of energy availability in regularly menstruating women. J Clin Endocrinol Metab.2003;88(1): 297-311.
18. Lowe P. Kovacs G. Howlett D. Incidence of polycystic ovaries and polycystic ovary syndrome amongst women in Melbourne. Australia. Aust N Z J Obstet Gynaecol.2005;45(1):17-9.
19. Meyer NL. Shaw JM. Manore MM. et al. Bone mineral density of Olympic-level female winter sport athletes. Med Sci Sports Exerc.2004;36(9):1594-601.
20. Naessen S. Carlstrom K. Garoff L. Glant R. Hirschberg AL. Polycystic ovary syndrome in bulimic women-an evaluation based on the new diagnostic criteria. Gynecol Endocrinol.2006;22(7):388-94.
21. Naessen S. Carlstrom K. Glant R. Jacobsson H. Hirschberg AL. Bone mineral density in bulimic women-influence of endocrine factors and previous anorexia. Eur J Endocrinol.2006;155(2):245-51.
22. Nattiv A. Loucks AB. Manore MM. Sanborn CF. Sundgot-Borgen J. Warren MP. American College of Sports Medicine. Position Stand. The female athlete triad. Med Sci Sports Exerc.2007;39(10): 1867-82.
23. Notelovitz M. Androgen effects on bone and muscle. Fertil Steril.2002;77(Suppl 4):S34-41.
24. Nystrom FH. Ohman PK. Ekman BA. Osterlund MK. Karlberg BE. Arnqvist HJ. Population-based reference values for IGF-I and IGF-binding protein-1: relations with metabolic and anthropomet-ric variables. Eur J Endocrinol. 1997;136(2):165-72.
25. Poovoa G. Roovete A. Hall K. Cross-reaction of serum somato-medin-binding protein in a radioimmunoassay developed for somatomedin-binding protein isolated from human amniotic fluid. Acta Endocrinol (Copenh).1984;107(4): 563-70.
26. Redman LM. Loucks AB. Menstrual disorders in athletes. Sports Med.2005;35(9):747-55.
27. Rickenlund A. Carlstrom K. Ekblom B. Brismar TB. von Schoultz B. Hirschberg AL. Hyperandrogenicity is an alternative mechanism underlying oligomenorrhea or amenorrhea in female athletes and may improve physical performance. Fertil Steril.2003;79(4): 947-55.
28. Rickenlund A. Thoren M. Carlstrom K. von Schoultz B. Hirschberg AL. Diurnal profiles of testosterone and pituitary hormones suggest different mechanisms for menstrual disturbances in endurance athletes. J Clin Endocrinol Metab.2004; 89(2):702-7.
29. Rotterdam ESHRE/ASRM-Sponsored PCOS Consensus Workshop Group. Revised 2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome. Fertil Steril.2004;81(1):19-25.
30. Sparling PB. Snow TK. Rosskopf LB. O'Donnell EM. Freedson PS. Byrnes WC. Bone mineral density and body composition of the United States Olympic women's field hockey team. Br J Sports Med.1998;32(4):315-8.
31. Storer TW. Magliano L. Woodhouse L. et al. Testosterone dose-dependently increases maximal voluntary strength and leg power. but does not affect fatigability or specific tension. J Clin Endocrinol Metab.2003;88(4): 1478-85.
32. Torstveit MK. Sundgot-Borgen J. The female athlete triad exists in both elite athletes and controls. Med Sci Sports Exerc.2005; 37(9):1449-59.
33. Turner CH. Three rules for bone adaptation to mechanical stimuli. Bone.1998;23(5):399-407.
34. World Health Organisation. Obesity: preventing and managing the global epidemic. Report of a WHO consultation. World Health Organ Tech Rep Ser.2000;894:i-xii. 1-253.
35. Writing Group for the ISCD Position Development Conference. Technical standardization for dual-energy x-ray absorptiometry. J Clin Densitom.2004;7(1):27-36.
36. Yeager KK. Agostini R. Nattiv A. Drinkwater B. The female athlete triad: disordered eating. amenorrhea. osteoporosis. Med Sci Sports Exerc.1993;25(7):775-7.